Not yet recruitingNot applicableNCT03358602

Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer

Studying Squamous cell carcinoma of the larynx

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tianjin Medical University Cancer Institute and Hospital
Principal Investigator
Lun Zhang, Ph.D, MD
Tianjin Medical University Cancer Institute and Hospital
Intervention
Radiotherapy(radiation)
Enrollment
158 target
Eligibility
18-75 years · All sexes
Timeline
2017 – 2027

Study locations (1)

Collaborators

Tianjin Medical University General Hospital · Tianjin Medical University Second Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03358602 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of the larynx

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of the larynx →

← Back to all trials